Acorda inks Ampyra generic settlements as it waits for patent appeal news
Acorda inks Ampyra generic settlements as it waits for patent appeal news Late last month, a court refused to block copies of Acorda’s Ampyra leading up to a patent appeal […]
News & Press
Mayo Clinic pinpoints genes that raise the risk of triple-negative breast cancer
Mayo Clinic pinpoints genes that raise the risk of triple-negative breast cancer The ability to identify women who face the highest risk of triple-negative breast cancer could save lives, but […]
Janssen, Bayer to close South Korean plants due to limited demand
Janssen, Bayer to close South Korean plants due to limited demand Janssen and Bayer are joining a long list of pharma companies closing their manufacturing facilities in South Korea. And […]
Allergan preludes major selloffs with $650M Almirall dermatology sale
Allergan preludes major selloffs with 0M Almirall dermatology sale Allergan, which is shopping assets to help turn its stock price around, has taken its first small step into selloff land. […]
Thomas Hughes leaves Zafgen to take CEO role at Navitor
Thomas Hughes leaves Zafgen to take CEO role at Navitor Thomas Hughes, Ph.D., has left Zafgen to become CEO at mTORC1 startup Navitor Pharmaceuticals. Hughes helmed Zafgen through a turbulent […]